EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 16 May 2019

Why a pharma investor quit his day job to follow a vision

Dr Riad Sherif, CEO, Oculis

Dr Riad Sherif is the CEO of Oculis which has a portfolio of ophthalmology medicines at various stages of development. Of course, before he made the leap into the hot seat at a pharma start-up, he thought hard about the company’s chances of success.

‘When investors look seriously at a company, they do a thorough IP review,’ he says. ‘Nobody will invest in innovation unless the company has technology that is patented. There is always risk with investment so there has to be a potential reward later on.’ Without investment, Oculis would not have been able to fund the clinical trials required to develop their products – and they would have no hope of reaching the market. Read more

News

EFPIA and CPIA Joint China/EU Pharmaceutical Industry Forum to Explore New Frontiers in Pharmaceutical...
08 May 2019

The workshop covers 4 different themes: Pharmaceuticals in the Environment, Pricing & Reimbursement, Compliance (marketing... Read more

Videos

European Excellence: Making the EU a world leader in medical R&D
We want Europe to be the world leader in medical R&D. The pharmaceutical industry created a trade surplus of €79.7... Read more

Health For All: Bringing innovative health solutions to all patients
#WeWontRest until we bring innovative health solutions to all patients. Read more

Stronger Together: Joining forces to fast-track results
Collaboration makes us stronger. Together we can transform the lives of patients - it is why #WeWontRest. Read more

Protect The Spark
Every new treatment or cure starts with the spark of an idea. That spark has to be nurtured and cared for through the... Read more

Events

EFPIA 2019 Annual Conference
27 June 2019 (Radisson Blu Royal Hotel, Brussels, Belgium)

Making connections can advance patient care and support the European economy at a time of significant change and challenge... Read more

EFPIA Oncology Data Summit: Unleashing the potential of data to improve cancer care
18 June 2019 (Brussels)

The Summit will bring together cancer and data players from around Europe to actively participate in identifying the... Read more

IMI Stakeholder Forum 2019
12 June 2019 (Royal Museums of Fine Arts of Belgium)

Brain health and disease in the digital era - 2020 and beyond Read more

WIN 2019 Symposium
23 June 2019 (Paris, France)

A symposium dedicated to Innovation and global deployment of Precision Oncology Read more

Building a healthier future for Europe

Manifesto: Building a healthier future for Europe
06 September 2018 (Publications)

Together we can transform the lives of patients - it is why #WeWontRest Read more

What we are reading

First glimpse of potential research partnerships in Horizon Europe
On 16 May 2019 (Science|Business)

A very early outline of the implementation plan for the Horizon Europe research programme offers the first glimpse of... Read more

HIV infections among children falling
On 13 May 2019 (UNAIDS)

The continuing fall in the number of children becoming infected with HIV is a major public health triumph. Globally,... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu